Cefpodoxime Proxetil 50 mg / 5mL Granule 50 mL
Comprehensive product details for sourcing and verification.
| NDC 11 | 65862-0140-50 |
|---|---|
| Product NDC | 65862-0140 |
| Generic Drug Name | Cefpodoxime Proxetil |
| Brand Name | Cefpodoxime Proxetil |
| Manufacturer | Aurobindo Pharma Limited |
| Strength | 50 mg / 5mL |
| Dosage Form | Granule |
| Drug Type | Oral |
| Package Quantity | 1 Bottle |
| Package Description | 1 BOTTLE in 1 CARTON (65862-140-50) / 50 mL in 1 BOTTLE |
| Active Ingredients | Cefpodoxime Proxetil |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Cefpodoxime Proxetil 50 mg / 5mL Granule is tracked under NDC 65862-0140-50 and rolls up into product family 65862-0140. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 1 Bottle.
- Manufacturer: Aurobindo Pharma Limited.
- Dosage form: Granule.
- Family size: 3 active presentations.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Drug Shortage Information
Public sources show a resolved shortage notice for cefpodoxime oral suspension and official FDA/DailyMed product references for the Aurobindo presentation.
Drug Shortage Index family
View Cefpodoxime Proxetil in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Cefpodoxime Proxetil.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Cefpodoxime Proxetil 50 mg / 5mL Granule 50 mL, NDC 65862-0140-50, is a Aurobindo Pharma Limited 50 mg / 5mL granule presentation packaged as 1 Bottle. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 65862-0140-50.
- Digits-only NDC 11: 65862014050.
- Possible 10-digit display format: 65862-140-50 (6586214050).
Helpful product links
- Search by brand name: Cefpodoxime Proxetil.
- Exact NDC 11: 65862-0140-50.
- Product family NDC: 65862-0140.
- Compare related presentations: Cefpodoxime Proxetil 50 mg / 5mL Granule 100 mL, Cefpodoxime Proxetil 50 mg / 5mL Granule 75 mL.
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.